Judy Liu, MD
Ophthalmology · Henderson, NVNPI 1689675720
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $998 of the $1,451 with a category attached, or 68.7%. 9 manufacturers reported payments, led by Alcon at 27.1% of the total. Reporting peaked in 2019 at $658 and has fallen 97.2% since, to $18 in 2025. That places this record below the midpoint for ophthalmology clinicians in NV, where the typical reported total is $1,540.
Across 20 payments — averaging $72.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$394
- Alimera Sciences, Inc.$269
- Regeneron Healthcare Solutions, Inc.$187
- Apellis Pharmaceuticals, Inc.$154
- Novartis$122
- Regeneron$121
- plus $205 from 3 others
Across 192 payments — averaging $3283.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$336K
- Genentech, Inc.$138K
- Novartis$125K
- Regeneron$31K
What the payments were for
- Food & beverage$99869%
- Education$413%
- Gifts$39427%
- Entertainment$191%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 1 | $394 |
| Alimera Sciences, Inc. | 2 | $269 |
| Regeneron Healthcare Solutions, Inc. | 4 | $187 |
| Apellis Pharmaceuticals, Inc. | 4 | $154 |
| Novartis | 1 | $122 |
| Regeneron | 2 | $121 |
| Genentech, Inc. | 2 | $113 |
| AbbVie(2 entities) | 3 | $73 |
| Optos, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$394
- EYLEA$223
- Iluvien$193
- BUPARLISIB$122
- Lucentis$100
- Non-Covered Product$100
How this compares
$1,451 in reported general payments places this provider in the 45th percentile of 121 ophthalmology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 187 | $5,842 |
| Prednisolone Acetate | 83 | $3,848 |
| MoxifloxacinMoxifloxacin Hcl | 37 | $1,152 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $147 |
| Brimonidine Tartrate | 19 | $105 |
| Timolol Maleate | 19 | $88 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Henderson
- Rene ZamoraHenderson$216K
- Darrick NeibaurHenderson$36K
- Peter DebryHenderson$10K
- Dan EisenbergHenderson$4K
- Rajy RouweyhaHenderson$3K
- Arshad KhananiReno$2M
- Eva LiangLas Vegas$496K
- Steven LeibowitzLas Vegas$147K
- Steve ChangReno$75K
- Curtis ManningSparks$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.